Moreover, post-NAC TIL levels and the expression of immune response genes associated with pCR decrease with tumor shrinkage in most cases, but residual HER2-type lesions have higher TIL levels, and an aggressive phenotype associated with tumor progression [13,15]. Here, ERBB2 is linked to neoplasm.